A rival's trial failure has challenged the shared scientific hypothesis between Amgen and Novartis.

1 report, 1 independent Updated Sep 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen Novartis

Keep exploring

Part of

Amgen and Novartis have developed similar drugs aimed at treating heart conditions. All 2 developments

Within Multiple companies, including Eli Lilly, Amgen, Ionis, and Novartis, are developing advanced experimental drugs for heart disease, including those targeting Lp(a).

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
- GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16

Related events

Novartis' drug failure has negatively impacted Amgen's financial outlook.Sep 8

Coverage

Newest first; wire copies grouped

Sep 13yahoo.com